Genetic alteration associated with chronic lymphocytic leukemia

被引:12
作者
Cotter, F. E. [1 ]
Auer, R. L. [1 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, Ctr Haematol, Inst Cell & Mol Sci, London E1 2AT, England
关键词
D O I
10.1159/000108315
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The genetics of B-cell chronic lymphocytic leukemia (B-CLL) differ considerably from most other forms of hematologic malignancy which are usually characterized by chromosome translocations. B-CLL typically contains chromosomal deletions and chromosomes 13q14 and 11q22 -> q23 are the most common. These two regions appear to share a common ancestral origin (Auer et al., 2007b). Overall, chromosomal abnormalities can be found in the majority of patients with B-CLL when using sensitive techniques (Dohner et al., 2000) and possibly reflects an underlying predisposition, with a small but significant number of familial cases. Although single and consistent abnormalities are most common, multiple rearrangements can occur, often with disease progression (Fegan et al., 1995; Dohner et al., 2000). Regions of recurrent deletion suggest the presence of tumor suppressor genes if following Knudson's theoretical 2-hit model. However, despite extensive sequencing analysis over the last decade and lack of pathogenic mutations identified, there has been a move away from this suggested hypothesis and alternative mechanisms of gene inactivation involving epigenetic silencing or haploinsufficiency may be considered as more likely in this disease. This review focuses on the common genetic abnormalities in B-CLL and relates them to some of the more recent hypotheses on inactivation of genes within these regions of deletion.
引用
收藏
页码:310 / 319
页数:10
相关论文
共 149 条
[71]   Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11 q23 deletion [J].
Joshi, Avadhut D. ;
Dickinson, John D. ;
Hegde, Ganapati V. ;
Sanger, Warren G. ;
Armitage, James O. ;
Bierman, Philip J. ;
Bociek, Robert G. ;
Devetten, Marcel P. ;
Vose, Julie M. ;
Joshi, Shantaram S. .
CANCER GENETICS AND CYTOGENETICS, 2007, 172 (02) :120-126
[72]   Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia [J].
Kalachikov, S ;
Migliazza, A ;
Cayanis, E ;
Fracchiolla, NS ;
Bonaldo, MF ;
Lawton, L ;
Jelenc, P ;
Ye, X ;
Qu, X ;
Chien, M ;
Hauptschein, R ;
Gaidano, G ;
Vitolo, U ;
Saglio, G ;
Resegotti, L ;
Brodjansky, V ;
Yankovsky, N ;
Zhang, P ;
Soares, MB ;
Russo, J ;
Edelman, IS ;
Efstratiadis, A ;
DallaFavera, R ;
Fischer, SG .
GENOMICS, 1997, 42 (03) :369-377
[73]   Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes [J].
Kalla, C ;
Nentwich, H ;
Schlotter, M ;
Mertens, D ;
Wildenberger, K ;
Döhner, H ;
Stilgenbauer, S ;
Lichter, P .
GENES CHROMOSOMES & CANCER, 2005, 42 (02) :128-143
[74]   Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes [J].
Kienle, DL ;
Korz, C ;
Hosch, B ;
Benner, A ;
Mertens, D ;
Habermann, A ;
Kröber, A ;
Jädger, U ;
Lichter, P ;
Döhner, H ;
Stilgenbauer, S .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3780-3792
[75]   Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status [J].
Kim, SZ ;
Chow, KU ;
Kukoc-Zivojnov, N ;
Boehrer, S ;
Brieger, A ;
Steimle-Grauer, SA ;
Harder, L ;
Hoelzer, D ;
Mitrou, PS ;
Weidmann, E .
LEUKEMIA & LYMPHOMA, 2004, 45 (10) :2037-2045
[76]   A transcription map of the minimally deleted region from 13q14 in B-cell chronic lymphocytic leukemia as defined by large scale sequencing of the 650 kb critical region [J].
Kitamura, E ;
Su, GF ;
Sossey-Alaoui, K ;
Malaj, E ;
Lewis, J ;
Pan, HQ ;
Hawthorn, L ;
Roe, B ;
Cowell, JK .
ONCOGENE, 2000, 19 (50) :5772-5780
[77]   TRISOMY-12 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CORRELATION WITH ADVANCED DISEASE, ATYPICAL MORPHOLOGY, HIGH-LEVELS OF SCD25, AND WITH REFRACTORINESS TO TREATMENT [J].
KNAUF, WU ;
KNUUTILA, S ;
ZEIGMEISTER, B ;
THIEL, E .
LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) :289-294
[79]   VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia [J].
Kröber, A ;
Seiler, T ;
Benner, A ;
Bullinger, L ;
Brückle, E ;
Lichter, P ;
Döhner, H ;
Stilgenbauer, S .
BLOOD, 2002, 100 (04) :1410-1416
[80]   Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia [J].
Liu, Y ;
Corcoran, M ;
Rasool, O ;
Ivanova, G ;
Ibbotson, R ;
Grander, D ;
Iyengar, A ;
Baranova, A ;
Kashuba, V ;
Merup, M ;
Wu, XS ;
Gardiner, A ;
Mullenbach, R ;
Poltaraus, A ;
Hultstrom, AL ;
Juliusson, G ;
Chapman, R ;
Tiller, M ;
Cotter, F ;
Gahrton, G ;
Yankovsky, N ;
Zabarovsky, E ;
Einhorn, S ;
Oscier, D .
ONCOGENE, 1997, 15 (20) :2463-2473